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P U B L I S H E D B Y E L S E V I E R I N C .LettersImpact of Secondhand
Smoke Exposure on
Smoking Cessation
in Cardiac PatientsSecondhand smoke (SHS) may act as a smoking cue
and prime dose of nicotine by activating acetylcho-
line receptors in brains to trigger smoking (1). SHS
exposure at home and having a smoking spouse or
peers predicted a lower likelihood of smoking cessa-
tion in cancer patients (2). Similar cross-sectional
ﬁndings were found in cardiac patients (3). This
study prospectively investigated the roles of SHS
exposure at home and outside of the home on
smoking cessation among cardiac outpatients in Hong
Kong (19.1% of men and 3.1% of women smoked daily
in 2012).
We used data from a randomized controlled trial,
which found no difference in smoking cessations of SHS Exposure and Smoking Cessation at 12-Month Follow-Up
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e.between stage-matched intervention and control
groups (4). A total of 1,495 (80.4%) adult smokers
attending the cardiac outpatient clinics in major
hospitals in Hong Kong were interviewed and fol-
lowed for up to 12 months. SHS exposure at home
was reported at baseline and categorized as none,
#1 h/day, and >1 h/day. The number of smoking
family members and exposure to SHS outside of the
home were categorized as none and any. Smoking
cessation was deﬁned as self-reported abstinence in
the past 30 days at 12-month follow-up. Sociodemo-
graphic characteristics, alcohol drinking, smoking
quantity and duration, long-term medication use, and
cardiac surgery received were recorded and treated as
potential confounders. The associations of having
smoking family member(s), SHS exposure at home,
and SHS exposure outside of the home with smoking
cessation were analyzed adjusting for intervention
allocation (Model 1), demographic characteristics and
smoking behaviors (Model 2), and clinical variables
(Model 3) using logistic regressions to yield adjusted
odds ratios (AORs).
The subjects (91.2% male, mean age 59  13.7
years) smoked for an average of 39.3  15.1 years
and consumed cigarettes for 41  27.4 pack-years.
Having smoking family member(s) (24.3%) was
associated with a lower AOR of 0.64 (95% conﬁdence
interval: 0.49 to 0.83) for smoking cessation, with
the same effect size after adjusting for various po-
tential confounders in different models (Table 1).
Any SHS exposure at home (20.2%) was associated
with an AOR of 0.65 (95% conﬁdence interval: 0.48
to 0.89) for smoking cessation, and increasing
duration of SHS exposure at home was associated
with decreasing odds of smoking cessation (p for
trend <0.001). SHS exposure outside the home
(89.6%) was not signiﬁcantly associated with smok-
ing cessation. Repeated analyses using 7-day absti-
nence as smoking cessation yielded similar results
(data not shown).
We found a prospective, dose-response, and robust
association between SHS exposure at home and lower
likelihood of smoking cessation in cardiac out-
patients. The magnitude of the association was in line
with our studies on adolescents, but is smaller than
studies on patients with cancer (AOR: 0.19 to 0.25)
and coronary heart disease (AOR: 0.26) (2,3), probably
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593due to the difference of research design, SHS mea-
surement, and disease status of patients. SHS expo-
sure outside of the home in our subjects was likely
and mostly from indoor workplaces, restaurants, and
streets where the exposure should be less intense
than at home. This may explain the nonsigniﬁcant
association between SHS exposure outside of the
home and smoking cessation.
Smoking cessation is one of the most effective
strategies for primary and secondary prevention of
cardiovascular disease (CVD), but it has received far
less attention than other CVD risk factors, such as
hypertension, hyperlipidemia, and diabetes (5).
Cardiologists play an important role in assisting
smokers to quit, particularly at the teachable mo-
ments of CVD diagnosis and hospitalization. Current
practice guidelines for smoking cessation on the
basis of evidence from pharmacological and behav-
ioral trials achieved <50% abstinence at 12-month
follow-up. In addition to standard smoking cessa-
tion practices, cardiologists should assess SHS
exposure in smokers and advise smokers to avoid
being exposed to SHS and smoking cues. Including
family members in smoking cessation counseling
may be warranted, particularly for CVD patients
who usually require lifestyle and behavioral modi-
ﬁcations using a family-centered approach. Future
interventions including counseling on SHS reduc-
tion may produce extra beneﬁcial effects on smok-
ing cessation in cardiac patients, in addition to the
beneﬁcial effects of avoiding SHS on cardiovascular
function in smokers.
All information was self-reported and subject to
reporting bias. Using biological markers of SHS
exposure could not distinguish places of exposure,
which were differentially associated with smoking
cessation. The generalizability of this study might be
limited, as it was originally designed as a trial and
adopted a nonrandom sampling method, although
the subjects were screened on the basis of a large pool
of patients (n ¼ 60,588).
We found that SHS exposure at home was associ-
ated with a lower likelihood of smoking cessation
among cardiac outpatients. Interventions to reduce
SHS exposure may increase quitting among cardiac
patients.Man Ping Wang, PhD
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Does the Type of Myocardial Infarction
Impact Management and Outcomes?Kumar et al. (1) showed that patients admitted to the
hospital with a principal diagnosis of acute myocar-
dial infarction (AMI) during weekends have a signiﬁ-
cantly higher risk of in-hospital mortality than those
admitted on weekdays. The authors suggest that
delayed access to cardiac catheterization during
weekends may explain this ﬁnding. We believe that
few clariﬁcations and alternative explanations are
worth consideration.
As the authors pointed out, weekend admissions
represent 26.1% of all admissions, instead of 28.5%
(2 of 7 days of the week). Selection bias is a plau-
sible explanation, as some patients with the least
severe clinical symptoms may delay the diagnostic
work-up and subsequently they would be admitted
on the next working day, whereas patients with
more severe symptoms are admitted the same
day. Assuming this, the next working day should
be associated with the highest number of admis-
sions and probably the lowest death rate of the
week.
The authors have performed an analysis of a large
database to address an important question. The
inability to distinguish between ST-segment eleva-
tion myocardial infarction (STEMI) and non–ST-
segment elevation myocardial infarction (NSTEMI)
